PSA PROFILES AFTER IODINE 125 PROSTATE BRACHYTHERAPY (BT)

被引：0
作者：
Crook, J. [1 ]
Gomez-Iturriga, A. [2 ]
Ma, C. [3 ]
Fung, S. [4 ]
机构：
[1] British Columbia Canc Agcy, Ctr Southern Interior, Dept Radiat Oncol, Kelowna, BC, Canada
[2] Univ Balboa, Dept Radiat Oncol, Balboa, Spain
[3] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada
[4] Princess Margaret Hosp, Biostat, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Five-year potency preservation after iodine-125 prostate brachytherapy
    Nishimura, Shuichi
    Yorozu, Atsunori
    Ohashi, Toshio
    Sakayori, Masanori
    Yagi, Yasuto
    Nishiyama, Toru
    Saito, Shiro
    Shiraishi, Yutaka
    Yoshida, Kayo
    Toya, Kazuhito
    Shigematsu, Naoyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (05) : 940 - 945
  • [22] Prostatic length predicts functional outcomes after iodine-125 prostate brachytherapy
    Pal, Raj P.
    Bhatt, Jaimin R.
    Khan, Masood A.
    Duggleby, Stuart
    Camilleri, Philip
    Bell, C. Richard
    Elwell, Christine
    Kunkler, Roger B.
    BRACHYTHERAPY, 2011, 10 (02) : 107 - 116
  • [23] A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S28 - S29
  • [24] Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
    Celada, F.
    Chicas, R.
    Soler, A.
    Roldan, S.
    Candela, C.
    Gimeno, J.
    Tormo, A.
    Perez-Calatayud, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S679
  • [25] Salvage brachytherapy with iodine 125 in local prostate cancer recurrence after primary radiotherapy
    Zimmermann, J.
    Osieka, R.
    Sablotny, J.
    Bruns, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 226 - 226
  • [26] PSA bounce after I-125 prostate brachytherapy correlates with better biochemical outcome
    Putora, P. M.
    Schwab, C.
    Engeler, D. S.
    Thoeni, A. F.
    Schiefer, J.
    Ackermann, D. K.
    Schmid, H. P.
    Plasswilm, L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (12) : 1069 - 1069
  • [27] A nalysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
    Du, E.
    Wang, Lin
    Li, Chang-ying
    Zhang, Chang-wen
    Qu, Yan-chun
    Liu, Ran-lu
    Xu, Yong
    Yang, Kuo
    Zhang, Zhi-hong
    ONCOTARGETS AND THERAPY, 2017, 10 : 2561 - 2567
  • [28] Radiomic and dosiomic prediction of biochemical failure after Iodine-125 prostate brachytherapy
    Nakano, M.
    Ishiyama, H.
    Kawakami, S.
    Sekiguchi, A.
    Kainuma, T.
    Tsumura, H.
    Hashimoto, M.
    Hasegawa, T.
    Tanaka, Y.
    Katakura, T.
    Murakami, Y.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1595 - S1596
  • [29] Calibration Seed Sampling for Iodine-125 Prostate Brachytherapy
    Crowe, Scott
    Kairn, Tanya
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2018, VOL 3, 2019, 68 (03): : 459 - 462
  • [30] INFLUENCE OF DOSE ON RISK OF ACUTE URINARY RETENTION AFTER IODINE-125 PROSTATE BRACHYTHERAPY
    Roeloffzen, Ellen M. A.
    Battermann, Jan J.
    van Deursen, Marijke J. H.
    Monninkhof, Evelyn M.
    Visscher, Mareije I.
    Moerland, Marinus A.
    van Vulpen, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1072 - 1079
12345